462 related articles for article (PubMed ID: 16804387)
1. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
Chamilos G; Kontoyiannis DP
Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
[TBL] [Abstract][Full Text] [Related]
2. Toward more effective antifungal therapy: the prospects of combination therapy.
Kontoyiannis DP; Lewis RE
Br J Haematol; 2004 Jul; 126(2):165-75. PubMed ID: 15238137
[TBL] [Abstract][Full Text] [Related]
3. Combination antifungal therapy: a critical review of the evidence.
Ostrosky-Zeichner L
Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
5. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
6. Management of immunocompromised patients with evidence of an invasive mycosis.
Walsh TJ
Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563
[TBL] [Abstract][Full Text] [Related]
7. Decision making in antifungal monotherapy versus combination therapy.
Lewis RE
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):61S-67S. PubMed ID: 16716124
[TBL] [Abstract][Full Text] [Related]
8. Current drug therapy of systemic mycoses: a review.
Yonga G
East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
10. Fungal infections in the immunocompromised host.
Hawkins C; Armstrong D
Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of invasive fungal diseases in neutropenic patients.
Almyroudis NG; Segal BH
Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
[TBL] [Abstract][Full Text] [Related]
12. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
13. Invasive mycoses: strategies for effective management.
Kontoyiannis DP
Am J Med; 2012 Jan; 125(1 Suppl):S25-38. PubMed ID: 22196206
[TBL] [Abstract][Full Text] [Related]
14. Pediatric antifungal therapy. Part I: focus on febrile neutropenia, invasive aspergillosis, combination antifungal therapy and invasive candidiasis in immunocompromised pediatric patients.
Allen U; Bow E; Doyle J; Richardson S; Robinson J; Rotstein C; Davies D; Hui C; Le Saux N; Laverdiere M; Read S
Minerva Pediatr; 2010 Feb; 62(1):57-69. PubMed ID: 20212399
[TBL] [Abstract][Full Text] [Related]
15. Echinocandins: a wealth of choice--how clinically different are they?
Zaas AK
Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
[TBL] [Abstract][Full Text] [Related]
16. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
Rogers TR; Frost S
Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
[TBL] [Abstract][Full Text] [Related]
17. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Katragkou A; Roilides E
Curr Opin Infect Dis; 2011 Jun; 24(3):225-9. PubMed ID: 21455060
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis for invasive mycoses in high risk patients.
Ullmann AJ; Cornely OA
Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
[TBL] [Abstract][Full Text] [Related]
19. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao PL; Huang LM; Hsueh PR
J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
